Stem cell treatment for worsening liver cirrhosis
Treatments studied
Part of Digestive system clinical trials.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign written consent and are willing to join the study
- You’re between 18 and 75 years old, any sex
- You have decompensated cirrhosis (a serious complication of cirrhosis) and a MELD score of 15–30
- In the last month, you do not have active bleeding from swollen veins, obvious severe brain confusion, hard-to-control fluid buildup, or hepatorenal syndrome
- You do not have an uncontrolled severe infection, and your kidney, sodium, and white blood cell levels are not severely abnormal
- You’re not having certain major risks (like recent TIPS/stent, recent alcohol non-stop use, pregnancy, severe allergies, recent stem-cell therapy, or active drug dependence)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine that helps the body make more blood cells (called GCSF and darbepoetin) either once or a few times can help people with early liver failure (decompensated cirrhosis). The goal is to see if it helps the liver work better and improve the patient's health.
This trial tests a new cell injection called HCL001 for people with decompensated cirrhosis (advanced liver scarring causing complications). The goal is to see if it's safe and helps improve liver function. It may be an option if you've tried standard treatments and meet specific health criteria.
This trial tests an experimental liver cell injection to see if it is safe and can help people with decompensated cirrhosis, a serious liver condition. If you qualify, you may receive this new treatment to potentially improve liver function.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
This study tests whether stem cells from umbilical cord blood can safely help people with advanced liver scarring (cirrhosis) caused by hepatitis B. It may offer a new option for those who haven't improved with usual treatments.
This trial tests whether stem cells from donated umbilical cords can help people with acute-on-chronic liver failure, a sudden worsening of chronic liver disease. The goal is to see if this treatment improves liver function and survival.
Hear when a new Decompensated Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.